Detecto EB-15-215 Bedienungsanleitung PDF herunterladen (Seite 241)

    225

2. Abahussein AA, al-Zayir AA, Mostafa WZ, Okoro AN (1993) Epidermolysis bullosa in the eastern

province of Saudi Arabia. Int J Dermatol 32:579–581

3. Altomare GF, Polenghi M, Pigatto PD, Nazzaro V, Piattoni F (1990) Dystrophic epidermolysis

bullosa inversa: a case report. Dermatologica 181:145–148

4. Arbiser JL, Fine JD, Murrell D, et al (1998) Basic broblast growth factor: a missing link between

collagen VII, increased collagenase, and squamous cell carcinoma in recessive dystrophic epidermo-

lysis bullosa. Mol Med 4:191–195

5. Armoni M, Schlesinger M, Vardy PA, Metzker A (1985) Phenytoin and junctional epidermolysis

bullosa. Arch Dermatol 121:168–169

6. Bauer EA, Gedde-Dahl T Jr, Eisen AZ (1977) e role of human skin collagenase in epidermolysis

bullosa. J Invest Dermatol 68:119–124

7. Beyne B (1982) Favorable eect of the sulfamethoxazole-trimethoprim combination on the evolu-

tion of congenital bullous epidermolysis of the dystrophic form. Nouv Presse Med 11:3730

8. Bugge TH, et al (1996) Loss of brinogen rescues mice from the pleiotropic eects of plasminogen

deciency. Cell 87:709–719

9. Caldwell-Brown D, Stern RS, Lin AN, Carter DM (1992) Lack of ecacy of phenytoin in recessive

dystrophic epidermolysis bullosa. N Engl J Med 327:163–167

10. Clark RA, et al (1982) Fibronectin and brin provide a provisional matrix for epidermal cell migra-

tion during wound reepithelialization. J Invest Dermatol 79:264–269

11. Clark RA (1990) Fibronectin matrix deposition and bronectin receptor expression in healing and

normal skin. J Invest Dermatol 94:128S–134S

12. Clark RA, Nielsen LD, Welch MP, McPherson JM (1995) Collagen matrices attenuate the colla-

gen-synthetic response of cultured broblasts to TGF-beta. J Cell Sci 108 (Pt 3):1251–1261

13. Clark RA, Ashcroft GS, Spencer MJ, Larjava H, FergusonMW(1996) Re-epithelialization of nor-

mal human excisional wounds is associated with a switch from alpha v beta 5 to alpha v beta 6

integrins. Br J Dermatol 135:46–51

14. Cooper TW, BauerEA(1984) erapeutic ecacy of phenytoin in recessive dystrophic epidermoly-

sis: a comparison of short- and long-term treatment. Arch Dermatol 120:490–495

15. Cunnane SC, Kent ET, McAdoo KR, Caldwell D, Lin AN, Carter DM (1987) Abnormalities

of plasma and erythrocyte essential fatty acid composition in epidermolysis bullosa: inuence of

treatment with diphenylhydantoin. J Invest Dermatol 89:395–399

16. Desmouliere A, Redard M, Darby I, Gabbiani G (1995) Apoptosis mediates the decrease in cellu-

larity during the transition between granulation tissue and scar. Am J Pathol 146:55–66

17. Eisenberg M, Stevens LH, Schoeld PJ (1978) Epidermolysis bullosa: new therapeutic approaches.

Australas J Dermatol 19:1–8

18. Falabella AF, Valencia IC, Eaglstein WH, Schachner LA (2000) Tissue-engineered skin (Apligraf)

in the healing of patients with epidermolysis bullosa wounds. Arch Dermatol 136:1225–1230

19. Featherstone C (2007) Epidermolysis bullosa: from fundamental molecular biology to clinical the-

rapies. J Invest Dermatol 127:256–259

20. Fine J-D (2007) Epidermolysis bullosa: a genetic disease of altered cell adhesion and wound healing,

and the possible clinical utility of topically applied thymosin b4. Ann NY Acad Sci 1112:396–406

21. Fine JD, Johnson L (1988) Ecacy of systemic phenytoin in the treatment of junctional epidermo-

lysis bullosa. Arch Dermatol 124:1402–1406

22. Fine JD, Eady RAJ (1999) Tetracycline and epidermolysis bullosa simplex – a new indication for

one of the oldest and most widely used drugs in dermatology? Arch Dermatol 135:981–982

1 2 ... 236 237 238 239 240 241 242 243 244 245 246 ... 356 357

Kommentare zu diesen Handbüchern

Keine Kommentare

Detecto EB-15-215 Bedienungsanleitung Seite 241

Kommentare zu diesen Handbüchern

Verwandte Produkte und Handbücher für Drucken & Scannen Detecto EB-15-215